Loading stock research
Loading stock research…
No token price observed
Observation time unavailableUnavailable
Buy from your own wallet on Solana mainnet. You review and sign every transaction.
Checking whether mainnet purchases are available…
You sign in your own wallet. Ovelo never holds your keys or funds.
Daily closes of CI, the underlying share. A token’s rights, price and liquidity can differ from the share.
Research observed · Source: Yahoo Finance, Wikipedia (CC BY-SA)
What you would hold, where it trades and where these numbers come from.
Observation time unavailableUnavailable
The company behind CI.
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g., governmental and non-governmental organizations, unions and associations). Cigna is incorporated in Delaware. The company ranked No. 15 in the 2023 Fortune 500 list of the largest U.S. corporations by total revenue, and the company took 68th place in the 2023 Forbes Global 2000 ranking. It has been embroiled in controversies, including engaging in automatic denials of insurance claims without reviewing them.
Observed · Source: Company profile
Momentum from daily closes of the underlying share.
Computed from daily closes of the underlying share, not the token. Not a recommendation.
Close of · Source: Yahoo Finance daily closesStale
Reported financials. They describe the company, not the token’s market value.
| Item | Period end | Value |
|---|---|---|
| Revenue (annual) | 31 Dec 2025 | $273.85B |
| Revenue (annual) | 31 Dec 2024 | $246.15B |
| Revenue (annual) | 31 Dec 2023 | $194.10B |
| Revenue (annual) | 31 Dec 2022 | $179.36B |
| Net income (annual) | 31 Dec 2025 | $5.96B |
| Net income (annual) | 31 Dec 2024 | $3.43B |
| Net income (annual) | 31 Dec 2023 | $5.16B |
| Net income (annual) | 31 Dec 2022 | $6.70B |
| Diluted EPS (annual) | 31 Dec 2025 | 22.18 USD/share |
| Diluted EPS (annual) | 31 Dec 2024 | 12.12 USD/share |
| Diluted EPS (annual) | 31 Dec 2023 | 17.39 USD/share |
| Diluted EPS (annual) | 31 Dec 2022 | 21.30 USD/share |
| Total assets (annual) | 31 Dec 2025 | $157.92B |
| Total assets (annual) | 31 Dec 2024 | $155.88B |
| Total assets (annual) | 31 Dec 2023 | $152.76B |
| Total assets (annual) | 31 Dec 2022 | $143.89B |
| Total debt (annual) | 31 Dec 2025 | $31.46B |
| Total debt (annual) | 31 Dec 2024 | $31.97B |
| Total debt (annual) | 31 Dec 2023 | $30.93B |
| Total debt (annual) | 31 Dec 2022 | $31.09B |
| Operating cash flow (annual) | 31 Dec 2025 | $9.60B |
| Operating cash flow (annual) | 31 Dec 2024 | $10.36B |
| Operating cash flow (annual) | 31 Dec 2023 | $11.81B |
| Operating cash flow (annual) | 31 Dec 2022 | $8.66B |
| Free cash flow (annual) | 31 Dec 2025 | $8.39B |
| Free cash flow (annual) | 31 Dec 2024 | $8.96B |
| Free cash flow (annual) | 31 Dec 2023 | $10.24B |
| Free cash flow (annual) | 31 Dec 2022 | $7.36B |
| Revenue (quarterly) | 30 Sept 2026 | $73.40B |
| Revenue (quarterly) | 30 Jun 2026 | $71.40B |
| Revenue (quarterly) | 31 Mar 2026 | $68.29B |
| Revenue (quarterly) | 31 Dec 2025 | $72.13B |
| Revenue (quarterly) | 30 Sept 2025 | $69.52B |
| Net income (quarterly) | 30 Sept 2026 | $1.44B |
| Net income (quarterly) | 30 Jun 2026 | $1.66B |
| Net income (quarterly) | 31 Mar 2026 | $1.65B |
| Net income (quarterly) | 31 Dec 2025 | $1.23B |
| Net income (quarterly) | 30 Sept 2025 | $1.87B |
| Diluted EPS (quarterly) | 30 Sept 2026 | 5.47 USD/share |
| Diluted EPS (quarterly) | 30 Jun 2026 | 6.29 USD/share |
| Diluted EPS (quarterly) | 31 Mar 2026 | 6.26 USD/share |
| Diluted EPS (quarterly) | 31 Dec 2025 | 4.64 USD/share |
| Diluted EPS (quarterly) | 30 Sept 2025 | 6.98 USD/share |
Reported dividends, splits and filings, each linked to its source.
Recent headlines about the company.